Royal Philips Stock CBOE EUROPE EQUITIES
Equities
NL0000009538
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- EUR | - |
|
Sales 2024 * | 18.71B 20.02B 27.49B | Sales 2025 * | 19.66B 21.04B 28.89B | Capitalization | 22.6B 24.18B 33.2B |
---|---|---|---|---|---|
Net income 2024 * | 189M 202M 278M | Net income 2025 * | 1.15B 1.23B 1.68B | EV / Sales 2024 * | 1.47 x |
Net Debt 2024 * | 4.93B 5.27B 7.24B | Net Debt 2025 * | 4.62B 4.94B 6.78B | EV / Sales 2025 * | 1.38 x |
P/E ratio 2024 * |
123
x | P/E ratio 2025 * |
22.3
x | Employees | - |
Yield 2024 * |
3.46% | Yield 2025 * |
3.59% | Free-Float | 83.89% |
Latest transcript on Royal Philips
Managers | Title | Age | Since |
---|---|---|---|
Roy Jakobs
CEO | Chief Executive Officer | 50 | 09-12-31 |
Director of Finance/CFO | 62 | 86-12-31 | |
Shez Partovi
CTO | Chief Tech/Sci/R&D Officer | 57 | 21-03-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 14-12-31 |
Sanjay Poonen
BRD | Director/Board Member | 55 | 21-12-31 |
Director/Board Member | 68 | 21-04-30 |
1st Jan change | Capi. | |
---|---|---|
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+1.98% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |